Jingjing Huang

Chongqing Key Laboratory Of Tumor Immune Regulation And Immune Intervention
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumors.

Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumors.

Journal: Journal for immunotherapy of cancer

Published: July 02, 2025

Log odds of positive lymph nodes as a prognostic marker in resectable triple negative breast cancer.

Log odds of positive lymph nodes as a prognostic marker in resectable triple negative breast cancer.

Journal: Scientific reports

Published: April 09, 2025

Impact of positive lymph nodes and RAI therapy on survival in N1b papillary thyroid carcinoma.

Impact of positive lymph nodes and RAI therapy on survival in N1b papillary thyroid carcinoma.

Journal: Frontiers in endocrinology

Published: December 24, 2024

Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognition.

Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognition.

Journal: Journal of translational medicine

Published: October 08, 2024

The role of immune cells and immune related genes in the tumor microenvironment of papillary thyroid cancer and their significance for immunotherapy.

The role of immune cells and immune related genes in the tumor microenvironment of papillary thyroid cancer and their significance for immunotherapy.

Journal: Scientific reports

Published: March 07, 2024

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection.

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection.

Journal: Frontiers in medicine

Published: June 16, 2022

A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains.

A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains.

Journal: Frontiers in immunology

Published: October 05, 2021

TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy.

TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy.

Journal: Frontiers in molecular biosciences

Published: August 10, 2021

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants.

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants.

Journal: Nature communications

Published: June 12, 2021

T Cell Immunity Evaluation and Immunodominant Epitope T Cell Receptor Identification of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein in COVID-19 Convalescent Patients.

T Cell Immunity Evaluation and Immunodominant Epitope T Cell Receptor Identification of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein in COVID-19 Convalescent Patients.

Journal: Frontiers in cell and developmental biology

Published: April 17, 2021

IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities.

IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities.

Journal: Frontiers in molecular biosciences

Published: March 02, 2021

A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2.

A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2.

Journal: Frontiers in immunology

Published: January 14, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026